Advocacy Actions
European Chamber Vice-President meets with Director-General for DG GROW Kerstin Jorna
On 22nd February, a group of European Chamber Advisory Council representatives led by Vice-President Stefan Bernhart met with European Commission Director-General for DG GROW Jerstin Jorna.
Read moreOnline Meeting with European Federation of Pharmaceutical Industries and Associations (EFPIA)
On 11th December 2023, European Chamber had an online meeting with European Federation of Pharmaceutical Industries and Associations (EFPIA).
Read moreMeeting with the Department of Pharmaceutical Service Management, National Healthcare Security Administration (NHSA)
On 11th August, Vice Chairs of the Pharmaceutical Working Group met with the Department of Pharmaceutical Service Management at the National Healthcare Security Administration (NHSA).
Read moreComments to National Healthcare Security Administration (NHSA) on the 2023 Renewal Rules for Negotiating Drugs
On 10th July, European Chamber Pharmaceutical Working Group submitted comments to National Healthcare Security Administration (NHSA) on the 2023 Renewal Rules for Negotiating Drugs.
Read moreMeeting with the Department of Pharmaceutical Pricing and Bidding and Procurement, National Healthcare Security Administration (NHSA)
On 10th July, Vice Chairs of the Pharmaceutical Working Group met with officials from the Department of Pharmaceutical Pricing and Bidding and Procurement of the National Healthcare Security Administration (NHSA).
Read moreCall for Comments on the Measures for the Administration of Advertisement Review of Drugs, Medical Devices, Health Food and Food for Special Medical Purposes (Draft)
On 28th June, the Agriculture, Food and Beverage Working Group, the FSMP Advisory Committe (Sub-working Group), Healthcare Equipment Working Group and Pharmaceutical Working Group submitted comments to the State Administration for Market Regulation on the Measures for the Administration of Advertisement Review of Drugs, Medical Devices, Health Food and Food for Special Medical Purposes (Draft).
Read moreComments to the National Medical Products Administration (NMPA) on the Circular on Tightening the Regulation of Marketing Authorisation Holders for Entrusted Production of Drugs
On 23rd June, European Chamber Pharmaceutical Working Group submitted comments to the National Medical Products Administration (NMPA) on the Circular on Tightening the Regulation of Marketing Authorisation Holders for Entrusted Production of Drugs.
Read moreComments to the National Healthcare Security Administration (NHSA) on 2023 National Reimbursement Drug List (NRDL) Adjustment Workplan
On 15th June, European Chamber Pharmaceutical Working Group submitted comments to the National Healthcare Security Administration (NHSA) on the 2023 National Reimbursement Drug List (NRDL) Adjustment Workplan.
Read moreMeeting with the Development and Research Centre (DRC) of the State Council on Healthcare Industry
Meeting with the Development and Research Centre of the State Council on Healthcare Industry
Read moreComments to National Medical Products Administration (NMPA) on the Administrative Measures for Drug Standards (Draft for comment)
European Chamber Pharmaceutical Working Group submitted comments to National Medical Products Administration (NMPA) on the Administrative Measures for Drug Standards (Draft for Comment), on 13th January 2023.
Read more